eBlu Solutions recently announced an impressive $4,000,000 funding round to further propel its innovative single portal software solution for infusible buy and bill specialty medications. The company's real-time benefit investigation process is revolutionizing the healthcare industry by providing comprehensive patient eligibility details, allowances, prior authorization requirements, and plan limitations all in one place. This substantial funding will be utilized to enhance the software, improving workflow processes, mitigating financial risks, and ultimately, streamlining the patient care journey from identification to treatment. With eBlu Solutions' cutting-edge technology focusing on efficiency and positive outcomes, this funding marks a significant step forward in shaping the future of healthcare delivery.
Breaking News: eBlu Solutions Secures $4M in Series A Round to Innovate Specialty Medication Management
Recently funded · $4.0M Series aSoftware Development
Get the full eBlu Solutions company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Aisot Technologies
Aisot Technologies is a Zurich-based AI company pioneering advanced, AI-driven investment solutions. Spun out of ETH Zurich in 2021, aisot leverages machine learning, large language models (LLMs), and quantitative methods to deliver precise, real-time investment insights. Its AI Insights Platform empowers asset managers, funds, family offices, and treasuries to anticipate market trends, optimize strategies, and mitigate risk. Recognized across Europe and the U.S., aisot partners with leading financial institutions to redefine quantitative investment management.
$2.5M Seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series a rounds
Companies that recently closed a Series a round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  Aligned Marketplace | Series a | $20.0M | today |
| 2 |  Vals AI United States | Series a | $40.0M | today |
| 3 |
.png&w=3840&q=75)